Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
Muhammad Awidi, Hematology and Oncology Fellow at Roswell Park Cancer Center, shared on LinkedIn.
”Osimertinib has changed the landscape for EGFR-mutated lung cancer, but its long-term heart safety has remained uncertain.
In our latest paper, we found that patients treated with osimertinib had higher rates of cardiomyopathy, ischemic heart disease, and heart failure compared with earlier-generation EGFR inhibitors. As survival improves, our findings highlight the need for ongoing cardiovascular monitoring to help prevent late toxicities.
Grateful to my outstanding co-authors Zaid Muhanna, Muntaser Zyoud, and Ahmad Issa three talented medical students I had the privilege to mentor on this project.”
Read the full Abstract here.
Stay updated with Hemostasis Today.
-
Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
-
Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
-
Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
-
Oct 29, 2025, 07:09Hritvik Jain and Andrew Goldsweig Sharedrisk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
-
Oct 29, 2025, 07:07Flora Peyvandi Shared an Article About Menstrual Bleeding and Bleeding Tendency in Dutch Adolescents
-
Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
-
Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
-
Oct 29, 2025, 07:15From the Lab to Prague․ Our ECTH 2025 Experience
-
Oct 29, 2025, 07:13Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
-
Oct 29, 2025, 07:09Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
-
Oct 30, 2025, 11:56Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
-
Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
-
Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
-
Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague
-
Oct 28, 2025, 06:46Alexandre Kauskot Attended ECTH in Prague